Safety and Efficacy of Intravenous Recombinant Tissue Plasminogen Activator Administered in the 3- to 4.5-hour Window in Korea
Affiliation:
2. Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan;3. Department of Neurology, University of Michigan, Ann Arbor, Michigan;4. Department of Radiology, University of Michigan, Ann Arbor, Michigan